Physiologic and pathologic changes in patients with continuous-flow ventricular assist devices.

  title={Physiologic and pathologic changes in patients with continuous-flow ventricular assist devices.},
  author={Romana John and A. K. Boyle and Frank D Pagani and Leslie Miller},
  journal={Journal of cardiovascular translational research},
  volume={2 2},
The clinical use of the newer continuous-flow pumps for mechanical circulatory support have resulted in superior outcomes including significantly reduced complication rates with improved durability over first generation pulsatile design pumps. However, as with all new technology, the newer LVADs have introduced a different set of management issues, as well as a unique risk profile into the mechanical circulatory support arena that were previously absent or unimportant with pulsatile LVADs… CONTINUE READING

From This Paper

Topics from this paper.
13 Citations
36 References
Similar Papers


Publications citing this paper.
Showing 1-10 of 13 extracted citations


Publications referenced by this paper.
Showing 1-10 of 36 references

Current axial flow pumps—HeartMate II and Jarvik LVADs

  • R. John
  • Seminars in Thoracic and Cardiovascular Surgery,
  • 2008
1 Excerpt

Effects of pulsatile- and continuous-flow left ventricular assist devices on left ventricular unloading

  • S. Garcia, F. Kamdar, A Boyle
  • Journal of Heart Transplantation,
  • 2008
1 Excerpt

Similar Papers

Loading similar papers…